e-ISSN 1309-2545      ISSN 1301-062X

Download Current Issue.

Volume : 24 Issue : 4 Year : 2018

Current Issue Archive Popular Articles Ahead of Print Submit Your Article Login
Turkish Journal of Neurology Indexed By

Intravenous Thrombolytic Therapy in Acute Ischemic Stroke: The Experience of Kütahya [Turk J Neurol]
Turk J Neurol. 2017; 23(4): 193-198 | DOI: 10.4274/tnd.35651  

Intravenous Thrombolytic Therapy in Acute Ischemic Stroke: The Experience of Kütahya

Mustafa Çetiner1, Sibel Canbaz Kabay1, Hasan Emre Aydın2
1Dumlupinar University Faculty of Medicine, Department of Neurology, Kutahya, Turkey
2Dumlupinar University Faculty of Medicine, Department of Neurosurgery, Kutahya, Turkey

Objective: Stroke is a serious cause of mortality and disability. The caregiver of the patients may be adversely affected by this situation as well. In addition, stroke has a great economic burden on healthcare. Significant improvement has been achieved in the field of diagnosis, treatment, and care in the acute phase of the ischemic stroke in recent years. Thrombolysis with intravenous (IV) recombinant tissue type plasminogen activator (r-tPA) is the main treatment option in selected patients. The aim of our study was to share the results of intravenous (IV) thrombolytic therapy applied to patients with acute ischemic stroke in our clinic.
Materials and Methods: We evaluated the clinical data of 52 patients who were admitted to our clinic with ischemic stroke within the first 4.5 hours after onset of stroke symptoms, and were treated with IV thrombolytic therapy, between the May 2014 and June 2016. Demographic characteristics and clinical data were recorded.
Results: Twenty-three of the patients were male and 29 were female. The mean age was 70.7±12.8 years (range, 41-92 years). Intracranial hemorrhage after treatment was observed in 8 patients (15.4%). Of these, 6 patients (11.5%) had asymptomatic hemorrhage, 2 patients (3.8%) had symptomatic hemorrhage. The mean score of modified Rankin Scale (mRS) was 0-1 in 16 (30.8%) patients, 2-3 in 10 (19.2%) patients, and 4-5 in 13 (25%) patients. The mean mRS score of 7 (20%) patients with total anterior circulation infarct was 0-1. The mean mRS score of 8 (57.1%) patients with partial anterior circulation infarct was 0-1. Thirteen (25%) patients died within 3 months of the treatment.
Conclusion: Intravenous thrombolytic therapy is an effective and safe treatment that is easy to administer within 4.5 hours in patients with acute ischemic stroke. This treatment increases the number of ambulatory patients and reduces disability in selected patients.

Keywords: Acute ischemic stroke, thrombolytic therapy, disability

Mustafa Çetiner, Sibel Canbaz Kabay, Hasan Emre Aydın. Intravenous Thrombolytic Therapy in Acute Ischemic Stroke: The Experience of Kütahya. Turk J Neurol. 2017; 23(4): 193-198

Corresponding Author: Mustafa Çetiner, Türkiye

English Full Text
Download citation
Reference Manager
Share with email
Send email to author

Similar articles
Google Scholar

© Copyright 2019 Turkish Journal of Neurology
Home        |        Contact
LookUs & OnlineMakale